Target
Serine/threonine-protein kinase WNK1 [1-434]
Ligand
BDBM203827
Substrate
n/a
Meas. Tech.
In vitro MBP Phosphorylation Assay (MBP)
pH
7.3000±n/a
Temperature
298.1500±n/a K
IC50
6±0.0 nM
Comments
extracted
Citation
 Yamada, KPark, HMRigel, DFDiPetrillo, KWhalen, EJAnisowicz, ABeil, MBerstler, JBrocklehurst, CEBurdick, DACaplan, SLCapparelli, MPChen, GChen, WDale, BDeng, LFu, FHamamatsu, NHarasaki, KHerr, THoffmann, PHu, QYHuang, WJIdamakanti, NImase, HIwaki, YJain, MJeyaseelan, JKato, MKaushik, VKKohls, DKunjathoor, VLaSala, DLee, JLiu, JLuo, YMa, FMo, RMowbray, SMogi, MOssola, FPandey, PPatel, SJRaghavan, SSalem, BShanado, YHTrakshel, GMTurner, GWakai, HWang, CWeldon, SWielicki, JBXie, XXu, LYagi, YIYasoshima, KYin, JYowe, DZhang, JHZheng, GMonovich, L Small-molecule WNK inhibition regulates cardiovascular and renal function. Nat Chem Biol 12:896-898 (2016) [PubMed]  Article 
Target
Name:
Serine/threonine-protein kinase WNK1 [1-434]
Synonyms:
WNK1_HUMAN | WNK1 | HSN2 | KDP | KIAA0344 | PRKWNK1 | With-No-Lysine (K) Kinase 3 (WNK3)
Type:
n/a
Mol. Mass.:
47330.05
Organism:
Human
Description:
Q9H4A3 1-434 aa Carna Biosciences, cat no. 05-181
Residue:
434
Sequence:
MSGGAAEKQSSTPGSLFLSPPAPAPKNGSSSDSSVGEKLGAAAADAVTGRTEEYRRRRHTMDKDSRGAAATTTTTEHRFFRRSVICDSNATALELPGLPLSLPQPSIPAAVPQSAPPEPHREETVTATATSQVAQQPPAAAAPGEQAVAGPAPSTVPSSTSKDRPVSQPSLVGSKEEPPPARSGSGGGSAKEPQEERSQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKSVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR
  
Inhibitor
Name:
BDBM203827
Synonyms:
WNK463 (2) | WNK463 | N-(tert-butyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-oxadiazol- 2-yl)pyridin-2-yl)piperidin-4-yl)-1H-imidazole-5-carboxamide
Type:
Small organic molecule
Emp. Form.:
n/a
Mol. Mass.:
n/a
SMILES:
CC(C)(C)NC(=O)c1cncn1C1CCN(CC1)c1ccc(cc1)-c1nnc(o1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: